48,830
edits
Difference between revisions of "Cancer staging systems"
Jump to navigation
Jump to search
Cancer staging systems (view source)
Revision as of 14:58, 11 December 2013
, 14:58, 11 December 2013→Systems
| Line 5: | Line 5: | ||
*[[TNM staging system]] - most common, and used for the most common (adult) cancers. | *[[TNM staging system]] - most common, and used for the most common (adult) cancers. | ||
*World Health Organization (WHO) grading system - for [[CNS tumours]]. | *World Health Organization (WHO) grading system - for [[CNS tumours]]. | ||
*Durie-Salmon system - [[multiple myeloma]]. | *St. Jude system - pediatric pathology. | ||
*Durie-Salmon system - for [[multiple myeloma]]. | |||
*Ann Arbour system - for [[Hodgkin lymphoma]] and non-Hodgkin lymphoma (excluding [[mycosis fungoides]] and Sezary syndrome). | *Ann Arbour system - for [[Hodgkin lymphoma]] and non-Hodgkin lymphoma (excluding [[mycosis fungoides]] and Sezary syndrome). | ||
* | *Sheldon system - for [[urachal carcinoma]].<ref name=pmid22901574>{{Cite journal | last1 = Bruins | first1 = HM. | last2 = Visser | first2 = O. | last3 = Ploeg | first3 = M. | last4 = Hulsbergen-van de Kaa | first4 = CA. | last5 = Kiemeney | first5 = LA. | last6 = Witjes | first6 = JA. | title = The clinical epidemiology of urachal carcinoma: results of a large, population based study. | journal = J Urol | volume = 188 | issue = 4 | pages = 1102-7 | month = Oct | year = 2012 | doi = 10.1016/j.juro.2012.06.020 | PMID = 22901574 }}</ref> | ||
===Stage=== | ===Stage=== | ||